Streetbeat News

Analyst Ratings

ITCI

Canaccord Genuity analyst Sumant Kulkarni maintains a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) but lowers the price target from $101 to $100.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:51 pm

IRTC

Canaccord Genuity analyst William Plovanic maintains a Buy rating on iRhythm Technologies (IRTC) and raises the price target from $121 to $133.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:48 pm

HLMN

Canaccord Genuity analyst Brian McNamara maintains a Buy rating on Hillman Solns (NASDAQ:HLMN) and raises the price target from $11 to $12.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:46 pm

HCAT

Canaccord Genuity analyst Richard Close has maintained a Buy rating on Health Catalyst (NASDAQ:HCAT) but lowered the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:44 pm

GH

Canaccord Genuity analyst Kyle Mikson maintains a Buy rating on Guardant Health (NASDAQ:GH) but lowers the price target from $50 to $45.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:42 pm

EVH

Canaccord Genuity analyst Richard Close maintains a Buy rating on Evolent Health (EVH) but lowers the price target from $47 to $45.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:41 pm

ENOV

Canaccord Genuity analyst Caitlin Cronin maintains a Buy rating on Enovis (NYSE:ENOV) and raises the price target from $73 to $75.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:39 pm

DRVN

Canaccord Genuity analyst Brian McNamara maintains a Buy rating on Driven Brands Holdings (DRVN) but lowers the price target from $22 to $20.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:37 pm

RVNC

HC Wainwright & Co. analyst Douglas Tsao maintains a Buy rating on Revance Therapeutics (NASDAQ:RVNC) but lowers the price target from $15 to $12.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:32 pm

AMZN

GOOGL

META

MSFT

NFLX

NVDA

SOXX

XLK

Wedbush analyst Daniel Ives highlighted Nvidia's significant role in sparking a 'generational tech transformation' with its GPUs, driving the AI revolution. He compared the current AI investment wave to the pivotal moment in 1995, predicting a substantial increase in tech spending. Ives also noted the accelerated CapEx for AI by major tech companies like Microsoft, Alphabet, Meta Platforms, Amazon, and others, emphasizing the importance of not missing out on this transformation. The Technology Select Sector SPDR Fund and the iShares Semiconductor ETF saw premarket increases.

Portfolio Pulse from Shanthi Rexaline

February 23, 2024 | 2:24 pm